Background: Adenosine mediates its actions through four G protein-coupled receptors, A1, A2a, A2b and A3. The A1 receptor (A1R) is dominant in adipocytes where it mediates many actions that include inhibition of lipolysis, stimulation of leptin secretion and protection against obesity-related insulin resistance. Objective: The objective of this study is to investigate whether induced expression of A1Rs stimulates adipogenesis, or whether A1R expression is a consequence of cells having an adipocyte phenotype. Methodology: Human A1R and A2b receptors (A2bRs) were stably transfected into a murine osteoblast precursor cell line, 7F2. Adipogenesis was determined by lipid accumulation and expression of adipocyte and osteoblast marker molecules. Adenosine receptor expression and activation of associated signal molecules were also evaluated as 7F2 cells were induced to differentiate to adipocytes. Results: 7F2 cells transfected with the A1R showed increased adipocyte marker mRNA expression; lipoprotein lipase and glycerol-3-phosphate dehydrogenase were both upregulated, whereas the osteoblast marker alkaline phosphatase (ALP) was downregulated. When cultured in adipocyte differentiating media, such cells also showed increased adipogenesis as judged by lipid accumulation. Conversely, A2bR transfection stimulated osteocalcin and ALP expression, and in addition, adipogenesis was inhibited in the presence of adipocyte differentiation media. Adipogenic differentiation of naive 7F2 cells also resulted in increased expression of the A1R and reduced or modified expression of the A2a and A2bR. The loss of A2 receptors after adipogenic differentiation was accompanied by a loss of cyclic adenosine monophosphate and ERK1/2 signalling. Conclusion: These data show that expression of A1Rs induced adipocyte differentiation, whereas A2bR expression inhibited adipogenesis and stimulated an osteoblastic phenotype. These data suggest that targeting A1 and A2bR could be considered in the management of obesity and diabetes. Targeting adenosine signal pathways may be useful in treatment strategies for diseases in which there is an imbalance between osteoblasts and adipocytes.
Introduction
Adenosine receptors exist as four subtypes A1, A2a, A2b and A3 that signal primarily through the stimulation (A2a and A2b) and inhibition (A1 and A3) of cyclic adenosine monophosphate (cAMP) synthesis. We recently described the expression and function of adenosine receptors in a human osteoprogenitor cell line, as well as in human primary bone marrow-derived mesenchymal stem cells (MSC), and showed that the A2b receptor (A2bR) is functionally dominant in these cells.
1 CD73, the enzyme that dephosphorylates adenosine monophosphate to adenosine, is also a cell surface biomarker for MSC, suggesting that adenosine signalling could be involved in the differentiation process to adipocytes, chondrocytes and osteoblasts. 2 The A2a receptor (A2aR) has also been recently shown to be involved in the proliferation and differentiation of murine bone marrow-derived MSC. 2 Together, these findings imply a role for A2 receptors in the function and differentiation of MSC. A2 receptors are also known to be expressed on preadipocytes, whereas A1 receptors (A1R) are predominantly expressed on mature adipocytes. 3, 4 Adenosine, acting through A1R, has been implicated in many of the physiological functions of adipocytes. It has been associated, in particular, with an inhibition of lipolysis [5] [6] [7] and can be considered as a possible target for inclusion in the overall management of obesity. Furthermore, it is known that A1R activation mediates leptin secretion in animal models, 8 and blocking of the receptor or removal of endogenous adenosine reduces leptin secretion from isolated adipocytes. 9 The A1R also has a physiological role in protecting against obesity-related insulin resistance, 10 and agonism of the A1R has been shown to lower plasma-free fatty acids and glycerol in obese Zucker fatty animals. 7 Glucose-stimulated insulin and glucagon secretion were also elevated in A1R null mice when compared with wild-type animals. 11 In addition, consumption of large quantities of caffeine has been reported to be beneficial and associated with a reduced risk of type 2 diabetes, 12 however, the mechanisms involved remain unclear. Possible effects include glucose metabolism, insulin secretion or sensitivity, although such changes may also be attributed to other components, apart from caffeine, in coffee. 12 As there is an apparent switch from the predominant expression of A2Rs in MSC and preadipocytes to that of A1R in mature adipocytes, we have investigated whether A1R actually stimulates adipogenesis, or whether its expression is a consequence of cells differentiating to adipocytes. We thus overexpressed the A1R in preosteoblasts (7F2) that are capable of differentiating to adipocytes, 13 and examined adipogenesis. As A2bR is predominantly expressed in preosteoblasts, 1 we compared the results with cells overexpressed with A2bR. Furthermore, we investigated the expression of adenosine receptors, as these preosteoblasts were induced to differentiate to adipocytes and, in addition, examined the effect of adenosine receptor agonists on adipogenesis of 7F2 cells and 3T3L1 preadipocyte cells Alkaline phosphatase activity Alkaline phosphatase (ALP) activity was determined using the phosphatase substrate with alkaline buffer (SigmaAldrich). Briefly, cells were washed with PBS and 50 ml phosphatase substrate/alkaline buffer pH 10.3 was added to each well. After incubation for 20 min in the dark, absorbance at 405 nm was read on a SpectraCount microplate photometer (Canberra-Packard). ALP activity were normalised to protein concentration (Protein Assay kit from BioRad Laboratories, Hemel Hempstead, UK) or cell number (CellTiter 96 AQ ueous One Solution Cell Proliferation assay, Promega) as determined in parallel experiments.
Materials and methods

Materials
Real-time quantitative reverse transcription PCR Total cellular RNA was prepared using TRIzol reagent (Invitrogen); contaminating DNA was removed using the TURBO DNA free kit (Applied Biosystems, Warrington, UK). cDNA was prepared from 1 mg total RNA by heating for 1 h at 37 1C in the presence of Moloney murine leukemia virus reverse transcriptase, RNasin (ribonuclease inhibitor) and oligodeoxythymidilic acid (oligo(dT) 15 ). cDNA (1 ml, equivalent to 0.05 mg RNA) was subjected to PCR amplification, using primers as indicated in Table 1 . Primer sequences were designed, as far as possible, to be on different exons, using the Primer 3 software programme and gene sequences obtained from GenBank.
Real-time quantitative reverse transcription PCR was performed on an MX3000P thermal cycler system (Agilent Technologies, Wokingham, UK). The reaction mix contained 12.5 ml SYBR green Master Mix (Agilent Technologies), 1 ml of cDNA template, 1 ml (10 mM) of the forward and the reverse primers and 10. Western blotting analysis Cells were lysed in radioimmunoprecipitation assay buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.1% sodium dodecyl sulphate, 0.5% sodium deoxycholate) containing protease inhibitors cocktail solution (chymostatin, leupeptin, antipain and pepstatin all at 10 mg ml À1 ), 1 mM sodium orthovanadate and 0.1 mg ml À1 phenylmethylsulfonyl fluoride. Protein levels were quantified with the Bio-Rad protein assay (BioRad Laboratories). Cell lysates (15-30 mg of protein) and pre-stained protein markers (Cell Signaling Technology) were mixed with an equal volume of loading buffer (4% sodium dodecyl sulphate, 2% b-mercaptoethanol, 20% glycerol, 100 mM Tris-HCl, pH 6.8, 0.004% pyronin Y) and subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Proteins were transferred onto polyvinylidene fluoride membranes and incubated overnight at 4 1C, with specific antisera as indicated in the results section. Antisera were used at the recommended concentrations (usually 1:1000 or 1:2000). Secondary antibodies (1:5000) conjugated to horseradish peroxidase were applied for 1 h at room temperature and proteins were visualized with ECL Table 1 Primer sequences A2bR  TGCTCACACAGAGCTCCATC  AGTCAATCCAATGCCAAAGG  A3R  TCCCTGATTACCACGGACTC  TCCTTCTGTTCCCCACATTC  C/EBPb  CAAGCTGAGACGAGTACA  CAGCTGCTCCACTTCT  PPARg  TTTTCAAGGGTGCCAGTTTC  AATCCTTGGCCCTCTGAGAT  GPDH  ATGCTCGCCACAGAATCCACAC  AACCGGCAGCCCTTGACTTG  LPL  GCGTAGCAGGAAGTCTGACC  CATCAGGAGAAAGGCGACTG  Osteocalcin  AGACTCCGGCGCTACCTT  TAGGCGGTCTTCAAGCCATA  ARP  GAGGAATCAGATGAGGATATGGGA  AAGCAGGCTGACTTGGTTGC  CD73  CCTCTCAAATCCAGGGACAA  TTTGGAAGGTGGATTTCCTG  AD GGCGTGGTCTATGTGGAAGT GACCTTGATGCCAAATGCTT
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Plus reagent (GE Healthcare). To confirm equal sample loading, blots were stripped and re-probed with glyceraldehyde-3-phosphate dehydrogenase antiserum for 1 h at room temperature. For protein phosphorylation (ERK1/2) experimental cells were serum-starved for about 17 h, washed in PBS and incubated in serum-free media overnight at 37 1C in a 5% CO2:95% air atmosphere. Fresh media was added and incubation continued for a further 2 h before stimulation with test compounds as described in the results section. The stimulation was terminated by washing in ice-cold PBS containing 1 mM sodium orthovanadate, followed by lysis in ice-cold radioimmunoprecipitation assay buffer containing protease inhibitors.
Films were visualised and photographed using Multi Image light cabinet and AlphaImager documentation and analysis system (Cell Biosciences, Santa Clara, CA USA). 
Results
Stable transfection of A1R and A2bR in 7F2 cells
In the absence of adipocyte differentiation medium, A1R-transfected cells (7F2A1), when compared with control (pcDNA3. 1 alone) cells (7F2c), expressed increased levels of lipoprotein lipase and glycerol-3-phosphate dehydrogenase mRNA (Figure 1 ), two genes that are highly expressed in adipocytes. PPARg mRNA also tended to increase in 7F2A1 cells, although statistical significance was not reached. In addition, ALP enzyme activity was reduced in 7F2A1 cells, but expression of osteocalcin mRNA was unexpectedly elevated. In contrast to 7F2A1 cells, A2bR transfection (7F2A2b) had no effect on lipoprotein lipase, glycerol-3-phosphate dehydrogenase or PPARg expression, whereas osteocalcin mRNA and ALP activity were both increased (Figure 1 ). In the presence of adipocyte differentiation media, lipid accumulation as assessed microscopically was increased in 7F2A1, but inhibited in 7F2A2b cells when compared with 7F2c cells; the Oil red O staining pattern after 7 days of adipogenic differentiation is shown (Figures 2a-c) . Adenosine receptor expression in cultures undergoing adipocyte differentiation Relative adenosine receptor gene expression (mRNA) was assessed by quantitative reverse transcription PCR in naive 7F2 cells and as they were induced to differentiate to adipocytes (Figures 3a-d) . The values shown are based on relative ratios and gene of interest:acidic ribosomal protein (a house-keeping gene), and this ratio in control 7F2 cells (that is, 0 time point) was assigned a value of 1. A1R expression increased significantly (500 ± 170 fold, Po0.01) after 4 days of differentiation and peaked after 7 days (1550±230 fold; Po0.001) before apparently falling back, but still remained significantly elevated after 9 days (Figure 3a) . On the other hand, in the same experiments, A2aR and A2bR expression decreased (Po0.001) to p50% within 1 day of inducing differentiation (Figures 3b and c) .
Western blotting analysis was used to investigate changes in adenosine receptor protein expression during differentiation to adipocytes (Figure 3d ). A1R protein expression increased after 4 days, and in contrast to the mRNA, remained elevated for up to 12 days. The A2aR protein showed reduced expression after 4 days, consistent with changes in mRNA levels. The A2bR protein in control (day 0) 7F2 cells on western blotting showed two bands, a smaller size band, which was dominant and a slightly higher-molecular weight band that showed relatively low expression. On differentiation, there was a progressive A1 and A2b adenosine receptors modify adipogenesis B Gharibi et al increase in the larger molecular weight form of the A2bR with concomitant loss of the lower molecular weight form. A3R gene expression showed little change during adipogenic differentiation and the protein was undetectable on western blotting (data not shown). Glyceraldehyde-3-phosphate dehydrogenase expression confirmed equal sample loading in all analyses.
Adenosine receptor mediated signalling during adipocyte differentiation An overall stimulation, rather than an inhibition of cAMP, in response to adenosine (up to fourfold) and NECA (stable, universal adenosine receptor agonist) (up to 11 fold) shows that A2, rather than A1 and A3, are the major adenosine receptors in 7F2 cells (Figures 4a and b) . A weak stimulation of cAMP (onefold) by the A2a receptor agonist, CGS21680 (Figure 4c ) and the rank order of potencies, NECA4adenosine 4CGS21680, indicates that the dominant receptor in 7F2 preosteoblasts is of the A2b subtype and is consistent with our previous findings in osteoprogenitor cells. 1 After 7 days of adipocyte differentiation, the observed decrease in cAMP responses (Figures 4a-c) is consistent with a loss of A2 receptor protein (Figure 3 ). Figure 4d shows that the A1R selective agonist, CCPA, had little effect on forskolinstimulated cAMP in 7F2 cells and after 7 days of adipogenesis. NECA also stimulated CREB and ERK phosphorylation within 5-10 min in 7F2 cells, but there was no evidence of these molecules being phosphorylated after adipogenesis (Figures 4e and f) . Overall, these data indicate that A2b is the dominant adenosine receptor in 7F2 cells, and expression of this receptor and its associated signal molecules are markedly reduced on adipocyte differentiation.
Effects of adenosine receptor agonists on adipogenesis
Repeated (every 2-3 days) administration of NECA and the A1R agonist, CCPA at 1 and 10 mM in adipocyte differentiation (Figures 5a and b) . The stimulated accumulation of lipid also appeared to occur earlier in CCPA-treated cells (7 days as opposed to 9 days with NECA), indicating the importance of A1R in adipogenesis. The A2aR agonist, CGS21680 also stimulated lipid accumulation after days 9 and 12 of adipocyte differentiation, but only by 5-10% (data not shown). When similar experiments were carried out in 3T3L1 cells, differentiation media alone induced marked and rapid adipogenesis (80-90% of cells being positive for Oil Red O) within 3-5 days. NECA and CCPA had no further effect on adipogenesis (data not shown), but both compounds significantly stimulated Oil Red O accumulation, in a dose-related manner, after 10 days of exposure in the absence of differentiation media (Figures  5c and d) . The increase in Oil Red O staining observed was not due to changes in cell number (as determined using the MTS assay from Promega) after NECA or CCPA treatment (data not shown).
Discussion
The data presented here shows that A1R-transfected cells, in the absence of differentiation media, possess increased expression of several adipogenic markers, indicating that adipogenesis in these cells is higher than in the vector only controls. In the presence of adipocyte differentiation media, A1R-transfected cells clearly accumulate more lipid (lipogenesis) than control cells. Concomitant with adipogenesis is a loss of ALP activity (a marker of osteoblasts), but surprisingly, osteocalcin expression was significantly elevated. The reason for the rise in osteocalcin is not known, but may be related to activation by intermediate molecules downstream of the A1R. Interestingly, dihydroxy-cholecalciferol (1,25(OH)2D3)-stimulated adipocytic differentiation of porcine MSC was also accompanied by an increase in osteocalcin and a decrease in ALP. 16 Other researchers have shown that osteocalcin is produced in marrow stromal adipocytes and in human adipose tissue, where it has a role in metabolism. [17] [18] [19] Overall, our data extends and supports the finding that A1R expression stimulates lipid accumulation in ob17 preadipocytes. 20 However, animal studies suggest that the role of A1Rs in adipogenesis is much more complex. Male A1R (À/À) mice (X5 months) were, surprisingly, significantly heavier than A1R-positive mice, although there was no apparent weight difference in younger animals. 21 These findings appear to contradict the earlier data of LaNoue and Martin 22 who showed a loss of A1R in genetically obese rodents. The A1R is also strongly linked with insulin in adipose tissue, as its activation inhibits insulin release 23 and A1R (À/À) animals have a higher pancreatic insulin secretion, when compared with wild type animals. 
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We previously showed that the A2bR was important for the function of osteoprogenitor cells, 1 which concur with the findings in this study in which enhanced A2bR expression stimulates an increase in both osteocalcin and ALP. In addition, A2bR expression reduced lipid accumulation showing that lipogenesis and adipogenesis were also inhibited. As far as we are aware, this is a novel finding for the A2bR; however, as expression of ALP and osteocalcin increased in these experiments, the observed inhibition of adipogenesis may simply be indicative of an inverse relationship occurring between adipogenesis and ostoblastogenesis. 24 There are many reports showing that the A1R is highly expressed in adipocytes, whereas A2 receptors are predominant in preadipocytes; 3, 4, 18, 25 we thus investigated how adenosine receptor expression changes when cells are induced to differentiate along the adipocyte pathway. A1R mRNA expression increased sharply, but by day 9, these levels had fallen back but still remained above the level seen in undifferentiated cells (Figure 3a) . A1R protein expression remained elevated up to day 12 of adipocyte differentiation (Figure 3d ). This may suggest that there is increased mRNA translation to protein when the differentiating cells become mature adipocytes; on the other hand, mRNA for the A1R may be less stable when compared with other adenosine receptors. We have unpublished observations showing clear expression of the A1R protein, but barely detectable mRNA in HaCaT keratinocytes and HCA2 fibroblasts (JH). We also have unpublished data showing that A1R expression increases as the preadipocyte cell line, 3T3L1 differentiates into adipocytes (JH). In contrast to the A1R, there were also decreases in A2Rs during adipocyte differentiation, consistent with a role for these receptors in osteoblastogenesis. The observed changes with the A2bR protein may reflect increased phosphorylation and receptor inactivation 26 during adipogenesis. Supplementary Figure 1 shows that adenosine signalling in undifferentiated 7F2 cells is predominantly via A2bRs as A1, A2a and A3 receptor agonists were unable to induce ERK phophorylation and only the A2bR antagonist, MRS1706, inhibited the stimulatory action of NECA. This signalling is lost or reduced in 7F2 differentiated adipocytes as demonstrated by reductions in adenosine receptor agonist mediated cAMP responses and losses in ERK and CREB signalling in adipocytes (Figure 4) , consistent with the loss of A2 receptor protein on adipogenesis (Figure 3) . We clearly showed an increase in A1R protein expression after adipogenesisB, yet we were unable to demonstrate an inhibition of forskolinstimulated cAMP by CCPA. This may suggest that even after adipogenesis, A1R expression in context of the other adenosine receptors remains low, but still sufficient to drive adipogenesis. On the other hand, the lack of a CCPA -phenylisopropyladenosine. The reasons for this are unclear, but may simply reflect the different model systems used and the degree of adipocyte differentiation observed. They also suggested that adenosine may have a biphasic action and this is highly likely and dependent on the relative expression of the different adenosine receptors. The A1R is clearly a high affinity receptor and the A2bR is a low affinity receptor; 27 their activation is thus dependent on the adenosine concentration of the microenvironment. The observed effects of NECA and CGS21680 on cAMP accumulation in our naive preosteoblast 7F2 cells is similar to that described in preadipocytes. 3, 4 These authors, in summary also conclude, as we do, that adenosine is able to promote adipogenesis. 3, 4 In our differentiation experiments (Supplementary Figure 2) , we also showed that adipogenesis was associated with an increase in CD73 and a loss of adenosine deaminase expression, which could suggest that adenosine levels accumulate on adipocyte differentiation. The effects of adenosine receptor agonists on lipid accumulation were thus investigated. In the presence of differentiation media, NECA and, in particular, CCPA were both able to enhance adipogenesis of 7F2 cells. Although we were unable to replicate these findings in 3T3L1 cells because of marked and A1 and A2b adenosine receptors modify adipogenesis B Gharibi et al rapid adipogenesis on incubation with differentiation media, we were able to show that NECA and CCPA significantly induced adipogenesis in the absence of differentiation media. In summary, our data show that exogenous adenosine can stimulate adipogenesis of preosteoblasts and preadipocytes probably via activation of A1Rs. On the other hand, the A2bR appears to inhibit lipogenesis and adipogenesis and supports osteoblastogenesis. These data suggest that targeting adenosine receptors, in particular, antagonism of A1R, could be considered as additional therapy for the management of obesity-related diseases. A1 and A2b adenosine receptors modify adipogenesis B Gharibi et al
